08h00 - 16h30
Print Bulletin PDF
Health Canada released the alert, Health Canada informing Canadians of risks related to certain preservatives in cosmetics, non-prescription and natural health products. The alert highlights the potential risks when using leave-on cosmetics, non-prescription and natural health products containing Methylisothiazolinone and Methylchloroisothiazolinone (MI/MCI). The use of a leave-on product with MI/MCI may result in symptoms such as, a red rash or bumps; itching (which may be severe); swelling, burning, or tenderness of the skin; dry, cracked or scaly skin; and/or blisters (draining fluid and crusting).
The alert states that “after June 14, 2016, all products intended for use by children under the age of three that contain MI/MCI should no longer be available for purchase. All other leave-on products containing MI/MCI should no longer be available for purchase after December 31, 2016.”
The Cosmetic Hotlist already includes a prohibition of MI/MCI in combination in leave-on products. This alert further expands on the restrictions in their use.
Click to view the alert:http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58290a-eng.php?utm_source=twitter_hc&utm_medium=social_en&utm_content=may10_mci&utm_campaign=social_media_16
How Bureau Veritas Can Help
Our knowledgeable professionals can design a program to meet your specific needs - whether it be to demonstrate quality and safety control, identify which product offers the best value, which product your customers prefer, or if the product meets your quality requirements.
For over 35 years, Bureau Veritas has worked successfully with top retailers and manufacturers around the world to help them better manage risk and regulatory compliance. If you have any questions, please contact your customer service representative or email: firstname.lastname@example.org.